Malignant neoplasm of stomach
Chapter 2:Neoplasms
ICD-10 C16 is a billable code used to indicate a diagnosis of malignant neoplasm of stomach.
Malignant neoplasm of the stomach, commonly referred to as gastric cancer, is a significant health concern worldwide. It arises from the gastric epithelium and can be associated with various risk factors, including chronic infection with Helicobacter pylori (H. pylori), dietary factors, and genetic predispositions. Gastric cancer is often asymptomatic in its early stages, leading to late diagnosis and poor prognosis. Symptoms may include abdominal pain, weight loss, nausea, and changes in appetite. The disease is staged using the TNM classification system, which assesses tumor size (T), lymph node involvement (N), and presence of metastasis (M). Treatment options typically include surgical resection, such as gastrectomy, chemotherapy, and radiation therapy, depending on the stage of the cancer. Early detection and intervention are crucial for improving outcomes, making awareness of risk factors and symptoms essential for healthcare providers.
Detailed pathology reports, staging information, and treatment plans.
Diagnosis and management of gastric cancer, follow-up care post-gastrectomy.
Ensure accurate documentation of tumor size, location, and lymph node involvement.
Endoscopy reports, biopsy results, and H. pylori testing.
Evaluation of gastric symptoms, management of H. pylori infection.
Document any findings from endoscopic procedures and treatment responses.
Used for patients diagnosed with gastric cancer requiring surgical intervention.
Operative report detailing the procedure and findings.
Oncology and surgery must coordinate documentation for accurate coding.
The primary risk factor for gastric cancer is chronic infection with Helicobacter pylori, which can lead to inflammation and changes in the gastric epithelium.
